Breaking News, Collaborations & Alliances

Bacthera Joins Microbiome Therapeutics Innovation Group

Alliance expected to accelerate microbiome therapeutic product development and manufacturing.

The Microbiome Therapeutics Innovation Group (MTIG) announced the addition of Bacthera to its coalition of companies leading the research and development of FDA-approved microbiome therapeutic drugs and microbiome-based products to address unmet medical needs, improve clinical outcomes, and reduce health care costs. Bacthera is a specialized contract development and manufacturing organization (CDMO) that offers services across the Live Biotherapeutics Products (LBP) life cycle and process cha...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters